Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Toll-like receptor 9 agonists as cancer therapeutics.
Holtick U, Scheulen ME, von Bergwelt-Baildon MS, Weihrauch MR. Holtick U, et al. Among authors: weihrauch mr. Expert Opin Investig Drugs. 2011 Mar;20(3):361-72. doi: 10.1517/13543784.2011.553187. Epub 2011 Jan 22. Expert Opin Investig Drugs. 2011. PMID: 21254877 Review.
Nail dystrophy due to dose-intensive chemotherapy.
Weihrauch MR, von Bergwelt-Baildon MS. Weihrauch MR, et al. Int J Hematol. 2009 Jul;90(1):6-7. doi: 10.1007/s12185-009-0355-9. Epub 2009 Jun 20. Int J Hematol. 2009. PMID: 19543953 No abstract available.
Analysis of Tie2-expressing monocytes (TEM) in patients with colorectal cancer.
Goede V, Coutelle O, Shimabukuro-Vornhagen A, Holtick U, Neuneier J, Koslowsky TC, Weihrauch MR, von Bergwelt-Baildon M, Hacker UT. Goede V, et al. Among authors: weihrauch mr. Cancer Invest. 2012 Mar;30(3):225-30. doi: 10.3109/07357907.2011.636114. Epub 2011 Dec 15. Cancer Invest. 2012. PMID: 22171993
CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential.
Kondo E, Gryschok L, Klein-Gonzalez N, Rademacher S, Weihrauch MR, Liebig T, Shimabukuro-Vornhagen A, Kochanek M, Draube A, von Bergwelt-Baildon MS. Kondo E, et al. Among authors: weihrauch mr. Clin Exp Immunol. 2009 Feb;155(2):249-56. doi: 10.1111/j.1365-2249.2008.03820.x. Epub 2008 Nov 24. Clin Exp Immunol. 2009. PMID: 19040609 Free PMC article. Review.
Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer.
Weihrauch MR, Ansén S, Jurkiewicz E, Geisen C, Xia Z, Anderson KS, Gracien E, Schmidt M, Wittig B, Diehl V, Wolf J, Bohlen H, Nadler LM. Weihrauch MR, et al. Clin Cancer Res. 2005 Aug 15;11(16):5993-6001. doi: 10.1158/1078-0432.CCR-05-0018. Clin Cancer Res. 2005. PMID: 16115944 Clinical Trial.
33 results